Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Expert Opinion on Drug Delivery|October 17, 2022
Long-acting HIV pre-exposure prophylaxis (PrEP) approaches: recent advances, emerging technologies, and development challengesVivek Agrahari, Sharon M Anderson, M Melissa Peet, et al.
Pharmaceutics|August 4, 2019
Topical Inserts: A Versatile Delivery Form for HIV PreventionM Melissa Peet, Vivek Agrahari, Sharon M Anderson, et al.
International Journal of Pharmaceutics|April 22, 2020
Pharmacokinetics of a weekly transdermal delivery system of tenofovir alafenamide in hairless ratsYing Jiang, Xinyi Gao, Onkar N Singh, et al.
Frontiers in Cellular and Infection Microbiology|March 30, 2022
Vaginal Microbiota and Mucosal Pharmacokinetics of Tenofovir in Healthy Women Using a 90-Day Tenofovir/Levonorgestrel Vaginal RingAndrea R Thurman, Jacques Ravel, Pawel Gajer, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 26, 2024
Formulation development of dual-compartment topical inserts combining tenofovir alafenamide and elvitegravir for flexible on-demand HIV preventionVivek Agrahari, M Melissa Peet, Neelima Chandra, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 4, 2016
A Site-Specific, Sustained-Release Drug Delivery System for Aneurysmal Subarachnoid HemorrhageDaniel Hänggi, Nima Etminan, Hans Jakob Steiger, et al.
The Journal of Infectious Diseases|December 4, 2025
Partial post-exposure protection by topical inserts containing tenofovir alafenamide fumarate/elvitegravir in a macaque model of rectal SHIV infectionNatalia Makarova, Tyana Singletary, M Melissa Peet, et al.
Pageof 3